23 / 88
23
Sunday, 18 June 2017
/ Scientific Programme
WFSBP 2017
SUN
002
The efficacy of minocycline as an adjunctive
treatment for major depressive disorder: A double blind,
randomised, placebo controlled trial
Olivia Dean, Australia
B. Kanchanatawan, M. Ashton, M. Maes, L. Berk,
A. Sughondhabirom, S. Tangwongchai, C. Ng, K. Hasebe,
C. Bortolasci, K. Walder, M. Berk
003
Expression and subcellular localization of sero-
tonin transporter in LCLs as putative biomarker for
antidepressant response
Abdul-Karim Barakat, Germany
C. Scholl, S. Lucae, M. Ising, A. Kalayda, U. Jaehde,
J. Stingl
004
The place of Electroconvulsive Therapy in the
treatment of depression in France: A comparison of
practices with international recommendations
Pierre-Michel Llorca, France
T. Charpeaud, A. Tremey, B. Aouizerate, P. Courtet
005
Prediction of electroconvulsive therapy response
and remission in major depression: A meta-analysis
Linda van Diermen, Belgium
S. Van Den Ameele, A. M. Kamperman, B. C. G. Sabbe,
V. Tom, D. Schrijvers, T. K. Birkenhäger
006
rTMS long-term prevention of depressive relapse /
recurrence does not increase risk of switching to mania
even in patients with first depressive episode: A ran-
domised controlled trial
Zhang-Jin Zhang, Hong Kong
H.-N. Wang, X.-X. Wang, Q.-R. Tan
T6: BIPOLAR DISORDERS: BASIC/ CLINICAL
S-04
SYMPOSIUM
10:15–11:45
Auditorium 10+11+12
Pathways of neuroprogression in Bipolar Disorder (BP)
Chair:
Benicio Frey, Canada
Co-Chair: Flavio Kapczinski, Brazil
001
Indicators or risk and resilience in the high-risk
offspring of bipolar parents
Anne Duffy, Canada
002
Lithium compared to quetiapine in the mainte-
nance phase after a first episode of mania
Michael Berk, Australia
003
Biological rhythms and illness progression in
Bipolar Disorder (BP)
Benicio Frey, Canada
004
Illness trajectories and neuroprogression in Bipolar
Disorder (BP)
Flavio Kapczinski, Brazil
T22: MOLECULAR NEUROBIOLOGY
S-05
SYMPOSIUM
10:15–11:45
Auditorium 15
Extracellular vesicles in neuropsychiatric diseases:
Basic mechanisms and biomarkers
Chair:
Takashi Kudo, Japan
Co-Chair: Dimitrios Kapogiannis, USA
001
Extracellular vesicles as a source of biomarkers for
Alzheimer's Disease
Dimitrios Kapogiannis, USA
002
Tau inside neutrally-derived exosome
Dominic Walsh, USA
003
Mechanisms of exosome involvement in neurode-
gerative diseases
Andrew Hill, Australia
004
Changes in exosomes proteins by the degree of
stress
Takashi Kudo, Japan
T22: MOLECULAR NEUROBIOLOGY
S-06
SYMPOSIUM
10:15–11:45
Congress Hall A 3
Drug addiction and GPCR heteroreceptor complexes:
What goes wrong in receptor plasticity as addiction
develops?
Chair:
Kjell Fuxe, Sweden
Co-Chair: Anita Hansson, Germany
001
Neurochemical mechanisms underlying goal-
directed and habitual drug seeking and how these
mechanisms produce compulsions: Focus on
Gq-coupled glutamate receptors
Kjell Fuxe, Sweden
002
Homo and heteroreceptor complexes participate
in learning and memory and as an emerging target for
treatment of cocaine addiction
Dasiel Borroto-Escuela, Sweden
003
Evidence for a role of A2A-D2 heteroreceptor
complexes in cocaine addiction
Malgorzata Filip, Poland
004
Dopamine D4-MOR interactions prevent
nigrostriatal dopamine pathway activation by morphine:
Relevance for drug addiction
Alicia Rivera, Spain